EXPO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Exponent Inc. (EXPO) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and projected growth in 2026 make it a solid investment opportunity despite recent insider selling and a slight price decline.
The stock's MACD is negative and expanding (-0.381), indicating bearish momentum. RSI is neutral at 30.658, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its support level of 67.962, suggesting a potential entry point for long-term investors.
Analysts project strong revenue growth and margin expansion in
Positive Q4 2025 financial results with revenue, net income, and EPS growth.
High cash reserves and shareholder-friendly actions like dividends and stock buybacks.
Increasing demand in regulatory and safety consulting for medical devices.
Insider selling has increased by 152% in the last month.
The stock has de-rated over the past year, and hedge funds remain neutral.
Current price is below the pivot level, indicating near-term weakness.
In Q4 2025, Exponent reported an 8% revenue increase to $147.4 million, net income growth of 4.97% to $24.8 million, and EPS growth of 6.52% to $0.49. The company also has strong cash reserves of $221.9 million and a high gross margin of 100%.
Recent analyst ratings are positive, with JPMorgan initiating coverage with an Overweight rating and a $100 price target, citing a strong rebound and growth potential. UBS raised its price target to $85, noting conservative guidance with upside potential. William Blair upgraded the stock to Outperform, highlighting revenue growth and AI benefits.
